Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ: VKTX )

30.89 +1.16 (+3.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,584,696
Open 30.13
Bid (Size) 31.00 (1)
Ask (Size) 31.05 (13)
Prev. Close 29.73
Today's Range 29.71 - 31.48
52wk Range 24.41 - 89.10
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Ignore the noise in GLP-1 stocks. Find the best value instead. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga

Performance

YTD
-24.88%
-24.88%
1 Month
+4.71%
+4.71%
3 Month
-34.60%
-34.60%
6 Month
-53.96%
-53.96%
1 Year
-50.62%
-50.62%

More News

Read More
Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.
Via Investor's Business Daily
Is Eli Lilly Stock a Buy?
Via The Motley Fool
The State of Weight Loss Drugs
Via The Motley Fool
Is Viking Therapeutics a Buy Right Now?
Via The Motley Fool
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Stocks to Buy With Less Than $40
Via The Motley Fool
BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Via Benzinga
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
Via Investor's Business Daily
MarketBeat Week in Review – 02/24 - 02/28
Via MarketBeat
Topics Economy World Trade
Exposures Interest Rates Tariff
1 Biotech Stock to Buy in 2025, and 1 to Avoid
Via The Motley Fool
2 Stocks That Could Soar Again in 2025
Via The Motley Fool
Has the Bubble Burst for Viking Therapeutics Stock?
Via The Motley Fool
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
Via The Motley Fool
Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
Via MarketBeat
Exposures Product Safety
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Via The Motley Fool
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Via The Motley Fool
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Via The Motley Fool
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Via The Motley Fool
Viking Therapeutics Stock Down Over 20% In 2025: Retail Traders Predict Where It Could End The Year
Via Stocktwits
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Via Stocktwits
Market Movers: $ASTS Surges Again, $PBI Gears Up For Earnings!
Via Talk Markets
Topics Stocks / Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.